Oleuropein exhibits anticarcinogen effects against gastric cancer cell lines

dc.contributor.authorTurkdogan, Mehmed Kursad
dc.contributor.authorKocyigit, Abdurrahim
dc.contributor.authorGuler, Eray Metin
dc.contributor.authorOzer, Omer Faruk
dc.contributor.authorDemir, Kuebra
dc.contributor.authorUgur, Halime
dc.date.accessioned2025-05-10T19:47:32Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground Oleuropein (OLE), the main phenolic compound of the olive fruit and leaves, has many heathful effects. Gastric cancer is the most fatal malignancy in many parts of the world and it is generally related to harmful dietetic factors. The anticarcinogenic role of OLE in gastric cancer has not been studied sufficiently yet. In this study, we aimed to research the cytotoxic, genotoxic and apoptotic effects of OLE on gastric adenocancer (AGS) cells in vitro. Methods and Results A standard cell line derived from gastric adeno cancer (AGS) cells was employed, and its performance following a 24-hour exposure to OLE at various doses was examined. The ATP cell viability assay, 2',7'-dichlorodihydrofluorescein-diacetate assay (H2DCF-DA) and alkaline single cell gel electrophoresis assay (Comet Assay) were used to study the cytotoxicity, production of reactive oxygen species (ROS) and genotoxicity respectively. The induction of apoptosis was discovered using flow cytometry. OLE reduced AGS cells viability about 60% at maximum concentration (500 mu mol/L) and also resulted in approximately 100% DNA damage and about 40% apoptosis with necrosis in AGS cells depending on the increased doses. Cell viability was also significantly decreased in relation to increased intracellular reactive oxygen species (ROS) levels (p < 0.05 - 0.001). Conclusions Oleuropein has shown significant anticarcinogen effects against gastric adenocancer (AGS) cells in vitro. Oleuropein, a nutrient rich in olive and olive oil, seems to be both protective and therapeutic against gastric cancer and may be a new chemotherapeutic agent in the future.
dc.description.sponsorshipBezmialem Vakif University Faculty of Medicine Scientific Research Project Fund [3.2014/35]
dc.description.sponsorshipThis work was supported by the Bezmialem Vakif University Faculty of Medicine Scientific Research Project Fund (project number:3.2014/35).
dc.identifier.doi10.1007/s11033-023-08773-y
dc.identifier.endpage9105
dc.identifier.issn0301-4851
dc.identifier.issn1573-4978
dc.identifier.issue11
dc.identifier.pmid37747682
dc.identifier.scopus2-s2.0-85172171244
dc.identifier.scopusqualityQ2
dc.identifier.startpage9099
dc.identifier.urihttps://doi.org/10.1007/s11033-023-08773-y
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11407
dc.identifier.volume50
dc.identifier.wosWOS:001073512100002
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofMolecular Biology Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectOleuropein
dc.subjectGastric cancer
dc.subjectApoptosis
dc.subjectDNA damage
dc.titleOleuropein exhibits anticarcinogen effects against gastric cancer cell lines
dc.typeArticle

Dosyalar